DSM Sells Styrene-Butadiene Rubber Business to Lion Chemical Capital LLC

DSM and Lion Chemical Capital LLC have announce the agreement on the sale of the DSM business unit SBR (styrene-butadiene rubber) to Lion Chemical Capital LLC. The transaction will take the form of an asset deal.

The sale is a result of DSM’s corporate strategy, Vision 2005: Focus & Value, which has transformed the company into a specialty company focusing on life science products and performance materials over the last few years. As a consequence, the SBR business no longer fits into DSM’s portfolio.

Lion Chemical Capital is pleased to have reached agreement on acquiring DSM SBR. Lion is committed to providing high quality products and exceptional service to its customers and plans to grow the business in the near future. It recognizes the dedicated workforce at the site and is determined to promote a safe and environmentally responsible workplace.

“Throughout the selling process we focused on finding a partner that recognizes and believes in the potential of the SBR business activities, and more specifically of our SBR plant in Baton Rouge” says Henk-Jan Koenen, President of DSM Copolymer Inc. “The future interests of all stakeholders in the business are secured by the transaction of our SBR unit to Lion.”

DSM and Lion Chemical Capital LLC expect to close the transaction in Q4 2005, subject to regulatory and legal approvals.

http://www.dsm.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.